RANKL biology: bone metabolism, the immune system, and beyond

• Main Authors: Takehito Ono, Mikihito Hayashi, Fumiyuki Sasaki, Tomoki Nakashima
• Format: Article
• Language: English
• Published: BMC 2020-02-01
• Series: Inflammation and Regeneration
• Subjects: RANKL; RANK; OPG; Bone; Immune system; Osteoimmunology
• Online Access: https://doi.org/10.1186/s41232-019-0111-3

Abstract Receptor activator of NF-κB (RANK) ligand (RANKL) induces the differentiation of monocyte/macrophage–lineage cells into the bone–resorbing cells called osteoclasts. Because abnormalities in RANKL, its signaling receptor RANK, or decoy receptor osteoprotegerin (OPG) lead to bone diseases such as osteopetrosis, the RANKL/RANK/OPG system is essential for bone resorption. RANKL was first discovered as a T cell-derived activator of dendritic cells (DCs) and has many functions in the immune system, including organogenesis, cellular development. The essentiality of RANKL in the bone and the immune systems lies at the root of the field of “osteoimmunology.” Furthermore, this cytokine functions beyond the domains of bone metabolism and the immune system, e.g., mammary gland and hair follicle formation, body temperature regulation, muscle metabolism, and tumor development. In this review, we will summarize the current understanding of the functions of the RANKL/RANK/OPG system in biological processes.